Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1988 Mar;26(3):405–408. doi: 10.1128/jcm.26.3.405-408.1988

Selective medium with DNase test agar and a modified toluidine blue O technique for primary isolation of Branhamella catarrhalis in sputum.

J L Soto-Hernandez 1, D Nunley 1, S Holtsclaw-Berk 1, S L Berk 1
PMCID: PMC266302  PMID: 3128575

Abstract

A selective medium with DNase test agar and incorporating vancomycin (10 micrograms/ml), trimethoprim (8 micrograms/ml), and amphotericin B (2 micrograms/ml) supported the growth of 305 Branhamella catarrhalis isolates. A modified toluidine blue O technique was used after 48 h of incubation in CO2 to overlay suspected B. catarrhalis colonies. A metachromatic color change was observed in 15 min, indicating DNase production. In 200 unselected sputum samples of hospitalized patients, this method was compared with routine microbiologic procedures; 31 B. catarrhalis isolates were recovered with the method, compared with 22 isolated from the clinical laboratory. This medium will be particularly useful for culture of sputum, which shows inflammatory cells and gram-negative diplococci on Gram-stained smears.

Full text

PDF
405

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad F., McLeod D. T., Croughan M. J., Calder M. A. Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections. Antimicrob Agents Chemother. 1984 Sep;26(3):424–425. doi: 10.1128/aac.26.3.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alvarez S., Jones M., Holtsclaw-Berk S., Guarderas J., Berk S. L. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Antimicrob Agents Chemother. 1985 Apr;27(4):646–647. doi: 10.1128/aac.27.4.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Corkill J. E., Makin T. A selective medium for non-pathogenic aerobic Gram negative cocci from the respiratory tract: with particular reference to Branhamella catarrhalis. Med Lab Sci. 1982 Jan;39(1):3–10. [PubMed] [Google Scholar]
  4. Doern G. V. Branhamella catarrhalis--an emerging human pathogen. Diagn Microbiol Infect Dis. 1986 Mar;4(3):191–201. doi: 10.1016/0732-8893(86)90098-2. [DOI] [PubMed] [Google Scholar]
  5. Doern G. V., Morse S. A. Branhamella (Neisseria) catarrhalis: criteria for laboratory identification. J Clin Microbiol. 1980 Feb;11(2):193–195. doi: 10.1128/jcm.11.2.193-195.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Doern G. V., Siebers K. G., Hallick L. M., Morse S. A. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis. Antimicrob Agents Chemother. 1980 Jan;17(1):24–29. doi: 10.1128/aac.17.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. JEFFRIES C. D., HOLTMAN D. F., GUSE D. G. Rapid method for determining the activity of microorganisms on nucleic acids. J Bacteriol. 1957 Apr;73(4):590–591. doi: 10.1128/jb.73.4.590-591.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Khan J. A., Sharp S., Mann K. R., Brewer J. Kingella denitrificans prosthetic endocarditis. Am J Med Sci. 1986 Mar;291(3):187–189. doi: 10.1097/00000441-198603000-00009. [DOI] [PubMed] [Google Scholar]
  9. Lachica R. V., Genigeorgis C., Hoeprich P. D. Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol. 1971 Apr;21(4):585–587. doi: 10.1128/am.21.4.585-587.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Riou J. Y., Guibourdenche M. Branhamella catarrhalis. New methods of bacterial diagnosis. Drugs. 1986;31 (Suppl 3):1–6. doi: 10.2165/00003495-198600313-00003. [DOI] [PubMed] [Google Scholar]
  11. Riou J. Y., Guibourdenche M. Diagnostic bactériologique des espèces des genres Neisseria et Branhamella. Ann Biol Clin (Paris) 1977;35(2):73–87. [PubMed] [Google Scholar]
  12. Sweeney K. G., Verghese A., Needham C. A. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains. Antimicrob Agents Chemother. 1985 Apr;27(4):499–502. doi: 10.1128/aac.27.4.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Van Hare G. F., Shurin P. A., Marchant C. D., Cartelli N. A., Johnson C. E., Fulton D., Carlin S., Kim C. H. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis. 1987 Jan-Feb;9(1):16–27. doi: 10.1093/clinids/9.1.16. [DOI] [PubMed] [Google Scholar]
  14. Wald E. R., Milmoe G. J., Bowen A., Ledesma-Medina J., Salamon N., Bluestone C. D. Acute maxillary sinusitis in children. N Engl J Med. 1981 Mar 26;304(13):749–754. doi: 10.1056/NEJM198103263041302. [DOI] [PubMed] [Google Scholar]
  15. Waller J. R., Hodel S. L., Nuti R. N. Improvement of two toluidine blue O-mediated techniques for DNase detection. J Clin Microbiol. 1985 Feb;21(2):195–199. doi: 10.1128/jcm.21.2.195-199.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES